| Home | E-Submission | Sitemap | Contact Us |  
top_img
Cancer Research and Treatment > Accepted Articles
doi: https://doi.org/10.4143/crt.2020.1001    [Accepted]
Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry
Hyeong In Ha1, Eun-Gyeong Lee2, Jiwon Lim3, So-Youn Jung2,4, Yoon Jung Chang5,6, Young-Joo Won3,6, Myong Cheol Lim1,6,7
1Center for Gynecologic Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
2Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea
3Division of Cancer Registration and Surveillance, National Cancer Control Institute, National Cancer Center, Goyang, Korea
4Cancer Healthcare Research Branch, Research Institute, National Cancer Center, Goyang, Korea
5Division of Cancer Control & Policy, National Cancer Control Institute, National Cancer Center, Goyang, Korea
6Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, Goyang, Korea
7Division of Tumor Immunology, Research Institute, National Cancer Center, Goyang, Korea
Correspondence  Young-Joo Won ,Tel: 82-31-920-2015, Fax: 82-31-920-2179, Email: astra67@ncc.re.kr
Myong Cheol Lim ,Tel: 82-31-920-1760, Fax: 82-31-920-1379, Email: gynlim@gmail.com
Received: October 1, 2020;  Accepted: November 18, 2020.  Published online: November 18, 2020.
ABSTRACT
Purpose
A prior history of breast cancer is a risk factor for the subsequent development of primary peritoneal, epithelial ovarian, and fallopian tubal (POFT) cancers. This study aimed to estimate the incidence of secondary POFT malignancy in breast cancer patients and to estimate the clinical outcomes of primary and secondary POFT cancer.
Materials and Methods
We searched the Korea Central Cancer Registry to find patients with primary and secondary POFT cancer who had breast cancer in 1999-2017. The incidence rate and standardized incidence ratio were calculated. Additionally, we compared the overall survival of patients with primary and secondary POFT cancer.
Results
Based on the age-standardized rate (ASR), the incidence of second primary POFT cancer after breast cancer was 0.0763 per 100,000 women, which increased in Korea between 1999 and 2017. Among the 30,336 POFT cancer patients, 25,721 were primary POFT cancer only, and 493 had secondary POFT cancer after a breast cancer diagnosis. Second primary POFT cancer patients were older at the time of diagnosis (55 vs. 53, p<0.0001) and had a larger proportion of serous histology (68.4% vs. 51.2%, p<0.0001) than patients with primary POFT. There were no differences between the two groups in tumor stage at diagnosis. The 5-year overall survival rates were 60.2% and 56.3% for primary and secondary POFT cancer, respectively (p=0.2161).
Conclusion
The incidence of second primary POFT cancer after breast cancer increased in Korea between 1999 and 2017. Besides, second primary POFT cancer patients were diagnosed at older ages and had more serous histology.
Key words: Primary peritoneal, Epithelial ovarian, Fallopian tube neoplasms, Ovarian neoplasms, Breast neoplasms, Second primary
Editorial Office
Korean Cancer Association
Room 1824, Gwanghwamun Officia
92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Cancer Association. All rights reserved.                 Developed in M2PI